References
- Vanden Bossche J, Dromer F, Improvisi I, Lozano-Chiu M, Rex JH, Sanglard D. Antifungal drug resistance in pathogenic fungi. Med Mycol 1998; 36 (Suppl. 1): 119–128.
- White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Gun Micro biol Rev 1998; 11: 382–402.
- Latge J-P. Aspergillus fumigatus and aspergillosis. Clin Micro-biol Rev 1999; 12: 310–350.
- Warnock DW Fungal infections in neutropenia: current problems and chemotherapeutic control. J Antimicrob Che-mother 1998; 41 (Suppl. D): 95–105.
- Denning DW, Venkateswarlu K, Oakley KL, et al. Itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 1997; 41: 1364–1368.
- Lai MH, Kirsch DR. Nucleotide sequence of cytochrome P450 L1A1 (lanosterol 14a-demethylase) from Candida albicans. Nucleic Acids Res 1989; 17: 804.
- Davis LG, Kuehl WM, Battey JF. Basic Methods in Molecular Biology, 2nd edn. Norwalk, CN.: Appleton & Lange, 1994.
- Van Nistelrooy JGM, van den Brink JM, van Kan JAL, van Gorcom RFM, de Waard MA. Isolation and molecular characterization of the gene encoding eburico114a-demethylase (CYP51) from Penicillium italicum. Mol Gen Genet 1996; 250: 725–733.
- Ochman H, Medhora MM, Garza D, Hartl DL. Amplification of flanking sequences by inverse PCR. In: PCR Protocols, Innis MA, Gelfand DH, Sninsky JJ, White TJ, eds. San Diego: Academic Press, 1990: 219–227.
- Marichal P, Koymans L, Willemsens S, et al. Contribution of mutations in the cytochrome P450 14a-demethylase (Erg 1 lp, Cyp51p) to azole resistance in Candida albicans. Microbiology 1999; 145: 2701–2713.
- Lamb DC, Kelly DE, Schunck W-H, et al. The mutation T315A in Candida albicans sterol 14a-demethylase causes reduced enzyme activity and fluconazole resistance through reduced affinity. J Biol Chem 1997; 272: 5682–5688.
- Boscott PE, Grant GH. Modeling cytochrome P450 14a-demethylase (Candida albicans) from P450cam. J Mol Graph 1994; 12: 185–192.
- Sanglard D, Ischer F, Koymans L, Bille J. Amino acid substitutions in the cytochrome P-450 lanosterol 14a-demethy-lase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antimicrob Agents Chemother 1998; 42: 241–253.
- Loffler J, Kelly SL, Hebart H, Schumacher U, Lass-Florl C, Einsele H. Molecular analysis of cyp51 from fluconazole-resistant Candida albicans. FEMS Microbiol Lett 1997; 151: 263–268.